Oncorus Stock Total Debt
| ONCRDelisted Stock | USD 0.04 0.01 14.71% |
Oncorus fundamentals help investors to digest information that contributes to Oncorus' financial success or failures. It also enables traders to predict the movement of Oncorus Stock. The fundamental analysis module provides a way to measure Oncorus' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Oncorus stock.
Oncorus |
Oncorus Company Total Debt Analysis
Oncorus' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Oncorus Total Debt | 70.65 M |
Most of Oncorus' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Oncorus is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
CompetitionBased on the latest financial disclosure, Oncorus has a Total Debt of 70.65 M. This is 97.43% lower than that of the Healthcare sector and 78.25% lower than that of the Biotechnology industry. The total debt for all United States stocks is 98.67% higher than that of the company.
Oncorus Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Oncorus' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Oncorus could also be used in its relative valuation, which is a method of valuing Oncorus by comparing valuation metrics of similar companies.Oncorus is currently under evaluation in total debt category among its peers.
Oncorus Fundamentals
| Return On Equity | -1.25 | |||
| Return On Asset | -0.32 | |||
| Current Valuation | 25.71 M | |||
| Shares Outstanding | 26.09 M | |||
| Shares Owned By Insiders | 12.69 % | |||
| Shares Owned By Institutions | 55.29 % | |||
| Number Of Shares Shorted | 447.72 K | |||
| Price To Book | 0.13 X | |||
| EBITDA | (75.42 M) | |||
| Net Income | (77.42 M) | |||
| Cash And Equivalents | 100.24 M | |||
| Cash Per Share | 3.86 X | |||
| Total Debt | 70.65 M | |||
| Debt To Equity | 0.72 % | |||
| Current Ratio | 6.42 X | |||
| Book Value Per Share | 1.19 X | |||
| Cash Flow From Operations | (61.69 M) | |||
| Short Ratio | 0.74 X | |||
| Earnings Per Share | (5.49) X | |||
| Target Price | 5.0 | |||
| Number Of Employees | 64 | |||
| Beta | 2.85 | |||
| Market Capitalization | 3.15 M | |||
| Total Asset | 145.59 M | |||
| Retained Earnings | (272.01 M) | |||
| Working Capital | 27.41 M | |||
| Z Score | -4.07 | |||
| Net Asset | 145.59 M |
About Oncorus Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Oncorus's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oncorus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oncorus based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Consideration for investing in Oncorus Stock
If you are still planning to invest in Oncorus check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oncorus' history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |